A carboplatin-resistant ovarian cancer cell line and its application
A technology for ovarian cancer cells and ovarian cancer, applied in the direction of tumor/cancer cells, animal cells, vertebrate cells, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0015] 1. Materials
[0016] OVCAR-3 cells were purchased from ATCC, USA.
[0017] Carboplatin (CBP) injection was purchased from Qilu Pharmaceutical Co., Ltd.: 50mg / 10ml / support.
[0018] Carboplatin working solution was prepared with cell culture medium (RPMI-1640+10% FBS, purchased from Gibco, USA).
[0019] 2. Steps of building a plant
[0020] 1) OVCAR-3 cells were cultured with RPMI-1640+10% FBS+100 U / ml penicillin+0.1 mg / ml streptomycin.
[0021] 2) OVCAR-3 cells were intervened with CBP at an initial concentration of 30 μM, and the drug-free medium (RPMI-1640+10% fetal bovine serum) was changed after 24 hours of CBP administration.
[0022] 3) Because carboplatin acts on DNA, the cells do not die immediately after adding the drug, and it takes about a month for the cells to return to a normal state after adding the drug once. After the cells grow stably, the shape is plump, and there are no floating dead cells, then start normal passage (P). After adding 30 μM car...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com